Antares Pharma Inc (ATRS) Return on Assets ROA from the first quarter of 2022 to first quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Mar 31 2022 to Mar 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Antares Pharma Inc   (NASDAQ: ATRS)


Antares Pharma Inc 's ROA from the first quarter of 2022 to the first quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Antares Pharma Inc 's ROA in the first quarter of 2022?
Antares Pharma Inc achieved a return on average assets (ROA) of 17.23 % in its first quarter of 2022, this is above ATRS's average return on assets of -14.01%.
Antares Pharma Inc assets over the 12 months ending in its first quarter of 2022 are valued at $233 million

ROA decreased relative to the period ending Dec 31 2021, due to the decline in net income.

However, within the Healthcare sector 62 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the fourth quarter of 2021 from 373 to 410.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter
Y / Y Total Assets Change 17.57 % -19.76 % 41.32 % 49.65 % 62.97 %
Y / Y Net Income Change - -36.4 % 7.95 % 103.22 % -
Net Income (TTM) in million 40 46 65 65 62
Return On Assets (TTM) 17.23 % 20.69 % 27.15 % 28.87 % 30.22 %
ATRS's Total Ranking # 410 # 373 # 185 # 162 # 133
Total Assets (TTM) in million 253 255 214 210 215
Seq. Total Assets Change -0.85 % 19.09 % 2.15 % -2.53 % -32.32 %
Seq. Net Income Change - 506.03 % 22.01 % 16.53 % -92.62 %

ATRS's 5 Years Annual ROA >> Back to ATRS Management Effectiveness >> Compare ATRS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 13
Sector # 63
Overall # 404

Return On Assets Statistics
High Average Low
34.69 %
-14.01 %
-46.4 %
(Dec 31 2020)   (Mar 31 2015)





Financial Statements
Antares Pharma Inc 's Assets $ 253 million ATRS's Balance sheet
Antares Pharma Inc 's Income $ -2 million Quarterly ATRS's Income Statement
ATRS's Income by Division See ATRS's Income by Division



Annual Return On Assets (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017
Y / Y Total Assets Change 21.9 % 62.35 % 46.11 % 18.75 % 12.17 %
Total Assets in million 255 209 129 88 74
Y / Y Net Income Change -17.64 % - - - -
Net Income in million 46 56 -2 -7 -17
Annual Return On Assets 18.13 % 26.84 % -1.57 % -7.38 % -22.52 %

ATRS's 5 Years Annual ROA >> Back to ATRS Management Effectiveness >> Compare ATRS ROA to its Competitors



Comment on ATRS's ROA in the fiscal year ending 2021
In the fiscal year 2021 Antares Pharma Inc 's ROA decreased compared to previous year to 18.13 %, due to deterioration of net income -17.64 % to $46.29 million, from $56.20 million a year ago, as ATRS's assets were $255.26 million.


More Return On Assets Ratios
ATRS's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ATRS's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ATRS's Competitors
Subscribers only: Roa for Antares Pharma Inc 's Suppliers
Subscribers only: Return On Assets for ATRS's Customers

You may also want to know
ATRS's Roi ATRS's Inventory Turnover Ratio ATRS's Growth Rates ATRS's Dividend Comparisons
ATRS's Profitability Ratios ATRS's Asset Turnover Ratio ATRS's Dividend Growth
ATRS's Roe ATRS's Valuation Ratios ATRS's Financial Strength Ratios ATRS's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2022, within Healthcare Sector ROA
REST EZ Inc.  43.62 %
Quidelortho Corp  42.64 %
Siga Technologies Inc  41.82 %
Uniqure N v   41.53 %
Effector Therapeutics Inc   40.45 %
Iteos Therapeutics Inc   40.00 %
Halozyme Therapeutics Inc   38.85 %
Avid Bioservices Inc   38.80 %
Reflect Scientific Inc  38.72 %
Molecular Templates Inc   38.05 %
Fulgent Genetics Inc   36.74 %
Rennova Health Inc   36.72 %
Carisma Therapeutics Inc   34.55 %
Regeneron Pharmaceuticals Inc   32.74 %
Innoviva Inc   32.02 %
Semler Scientific inc   30.94 %
Silo Pharma Inc  30.89 %
Co diagnostics Inc   30.58 %
Idexx Laboratories Inc  29.90 %
Elite Pharmaceuticals Inc   29.19 %
Vicarious Surgical Inc  27.93 %
Exelixis Inc   26.87 %
Integrated Biopharma Inc  26.21 %
Clene Inc   25.37 %
Maravai Lifesciences Holdings Inc   24.75 %
Mettler toledo International Inc   24.35 %
Retractable Technologies Inc  23.83 %
Nrc Health  23.77 %
Waters Corporation  22.81 %
Corcept Therapeutics Inc  21.87 %

Date modified: 2026-09-08T15:10:37+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.